More than half of those born after 1960 will develop cancer during their lifetime. Fortunately, owing to improved diagnosis and treatment, cure rates have risen steadily over the last three decades. With an increased survivorship, more will experience adverse effects of cancer therapeutics on the heart. As the oncologist's focus begins to encompass the issues of cancer survivorship, awareness of the management of cardiac toxicity would be prudent for all physicians looking after patients with cancer.
|Journal||Ulster Medical Journal|
|Publication status||Published - 01 Jan 2017|
FingerprintDive into the research topics of 'Cardiotoxicity Following Cancer Treatment.'. Together they form a unique fingerprint.
Biophysical correlates of base-mediated radiation cardiotoxicity in non-small cell lung cancerAuthor: Walls, G., Jul 2023
Supervisor: Butterworth, K. (Supervisor), Jain, S. (Supervisor) & Cole, A. (Supervisor)
Student thesis: Doctoral Thesis › Doctor of Philosophy